2015
DOI: 10.1007/s11910-015-0564-y
|View full text |Cite
|
Sign up to set email alerts
|

LRRK2 Pathways Leading to Neurodegeneration

Abstract: Mutations in LRRK2 are associated with inherited Parkinson’s disease (PD) in a large number of families, and the genetic locus containing the LRRK2 gene contains a risk factor for sporadic PD. The LRRK2 protein contains several domains that suggest a role in cellular signaling, including a kinase domain. It is also clear that LRRK2 interacts, either physically or genetically, with several other important proteins implicated in PD, suggesting that LRRK2 may be a central player in the pathways that underlie park… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
110
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 121 publications
(113 citation statements)
references
References 99 publications
3
110
0
Order By: Relevance
“…This differential recovery of PPIs is likely driven by literature bias toward proteins with known human disease associations. For example, LRRK2 is the focus of many investigations within PD research, [38] whereas MASL1 is relatively understudied. [21] Interestingly, this trend differs when considering the interactomes prior to applying the confidence threshold (i.e., when retaining all reported interactors regardless of replication; Figure 2B).…”
Section: Resultsmentioning
confidence: 99%
“…This differential recovery of PPIs is likely driven by literature bias toward proteins with known human disease associations. For example, LRRK2 is the focus of many investigations within PD research, [38] whereas MASL1 is relatively understudied. [21] Interestingly, this trend differs when considering the interactomes prior to applying the confidence threshold (i.e., when retaining all reported interactors regardless of replication; Figure 2B).…”
Section: Resultsmentioning
confidence: 99%
“…Mutations in LRRK2 are collectively the most common genetic cause of PD, associated with both familial and sporadic cases (Nalls et al, 2014; Paisan-Ruiz et al, 2004; Satake et al, 2009; Simon-Sanchez et al, 2009; Zimprich et al, 2004), highlighting the importance of LRRK2 in PD pathogenesis (Cookson, 2015; Pan and Yue, 2014; Tsika and Moore, 2012). Genetic analysis revealed striking age-dependent autophagy impairment and accumulation of a-synuclein as well as increases of apoptosis in the LRRK2 −/− kidney (Tong et al, 2012; Tong et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…To date, five mutations in LRRK2 have been shown unambiguously to segregate with familial PD and two additional variants have been nominated as risk factors (reviewed in [11, 12]). All of these LRRK2 mutations show age-dependent incomplete penetrance, meaning that some LRRK2 mutation carriers do not show clinical phenotypes during their lifetime [13]. …”
Section: Lrrk2 Is In a Pleomorphic Risk Locus For Pdmentioning
confidence: 99%
“…1) and mutated proteins have altered biochemical activity in vitro [17]. There are subtle differences between mutations, as the kinase domain mutations including G2019S and I2020T directly increase kinase activity [13] whereas those in the ROC-COR domains, the best studied of which are R1441C/G and Y1699C, decrease GTPase activity [1821]. However, it is thought that the physical proximity of two enzyme activities encoded in the same protein structure implies that they regulate each other and lead to a co-ordinated output in cellular signaling [22, 23].…”
Section: Lrrk2 Structure and Enzymatic Domainsmentioning
confidence: 99%